Metabolomics Market Growth

Metabolomics market growth is expected at a CAGR of 14.9% during the period 2021-2035

 

In addition to being a time and cost intensive process, metabolomics studies are fraught with several challenges; considering the expertise available with service providers to conduct such studies in an efficient manner, stakeholders are actively outsourcing their requirements

Roots Analysis has announced the addition of Metabolomics Market report to its list of offerings

Given the recent developments in biotechnology and medical research, metabolic analysis and metabolite profiling has become an integral part of therapeutic R&D and clinical development process. Players engaged in biomarker research, cancer therapy, diagnostics and personalized medicine have demonstrated a preference to continue relying on metabolomics service providers, in order to optimize discovery costs and research timelines. Additionally, owing to the increase in demand for high throughput analytical services and technologies for drug discovery and development, the metabolomics services market is projected to grow at a steady pace in the foreseen future.

To order this 240+ page report, which features 100+ figures and 130+ tables, please visit https://www.rootsanalysis.com/reports/metabolomics-services-market.html

Key Market Insights 

Around 180 industry and non-industry players currently claim to be engaged in providing metabolomics services
Majority of the players engaged in offering metabolomics services are large organizations (501-10,000 employees, 36%), followed by mid-sized players (51-500 employees, 23%) and very large (>10,000 employees, 15%) firms. Additionally, most of the service providers (~55%) are based in North America, followed those having headquarters in Europe and Asia.

Over 65% service providers offer metabolomics services to support biomarker discovery projects
Around 45 service providers state to have the necessary expertise to provide metabolomics services to support disease diagnostics applications, followed by those offering services for toxicology testing (19) and drug discovery (19). 

Partnership activity in this field has increased at a CAGR of 30.42%, between 2014 and 2020
Research agreements (~25%) emerged as the most common type of partnership model adopted by stakeholders engaged in this industry. Nearly 55% of the total deals were established post 2018, with the maximum activity being reported in 2021 (13). 

Value creation framework is used to address the unmet needs associated with metabolomics services
The framework highlights the implementation of several advanced tools and technologies at different stages of a metabolomics study. Further, it provides a detailed analysis on ease of implementation and associated risk in integrating such technologies, based on the trends highlighted in published literature and patents.

North America and Europe are anticipated to capture close to 70% of the market share, by 2035
Owing to increased investment in metabolomics-based research and growing initiatives for personalized medicine and drug discovery in Asia, the market is likely to grow at a relatively faster pace (15.72%) in the long term. Further, in 2035, academic and research institutes are expected to dominate the market, capturing around 50% of the market share among end users. 

You Can Download Free Sample PDF Copy of This Report At:
https://www.rootsanalysis.com/reports/metabolomics-services-market/request-sample.html

Key Questions Answered

• Who are the leading players engaged in providing metabolomics services?
• Which type of metabolomics services are most commonly offered by the companies?
• What is the relative competitiveness of different metabolomics service providers?
• What types of partnership models are commonly being adopted by stakeholders in this industry? 
• What is the likely performance enhancement via integrating novel tools / technologies with metabolomics studies?
• What are the major market trends and driving factors that are likely to impact the growth of metabolomics services market?
• How is the current and future market opportunity likely to be distributed across key market segments?

The financial opportunity within the metabolomics services market has been analyzed across the following segments:

• Area of Application
  • Biomarker Discovery
  • Personalized Medicine
  • Disease Diagnostics
  • Drug Discovery
  • Toxicological Testing
• Type of Metabolomics Service(s) Offered
  • Targeted Metabolomics 
  • Untargeted Metabolomics
• Type of Metabolome Profiling Technique Used
  • LC-MS 
  • GC-MS
  • NMR
• Type of End User
  • Research / Academic Institutes
  • Pharma / Biotech Firms
  • CROs
• Key Geographies 
  • North America
  • Europe
  • Asia
  • Latin America
  • Middle East and North Africa (MENA)
  • Rest of the World 

The report also features inputs from eminent industry stakeholders, according to whom, growing demand for biomarker discovery projects and case control studies will drive the growth of third-party service providers engaged in the metabolomics domain, in the coming future. The report includes detailed transcripts of discussions held with the following experts:

• Head of Metabolome Data Science, Small Company, Germany
• Indian Representative, Mid-sized Company, Austria
• Scientific Officer, Large Organization, Germany
• Chief Executive Officer, Small Company, Denmark
• Chairman and Chief Executive Officer, Small Company, France

The research includes profiles of key players (listed below); each profile features a brief overview of the company, recent developments (including partnerships and collaborations) and an informed future outlook. 

• biocrates life sciences 
• Creative Proteomics 
• DNA Xperts 
• Eremid Research Services 
• Human Metabolome Technologies (HMT)
• Metabo Profile 
• Metabolon 
• MS-Omics 
• Novelgene Technologies
• Synbio Technologies

For additional details, please email at sales@rootsanalysis.com

Contact:

Gaurav Chaudhary
Gaurav.chaudhary@rootsanalysis.com